96. Crohn disease Clinical trials / Disease details
Clinical trials : 2,400 / Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04502303 (ClinicalTrials.gov) | September 2020 | 4/8/2020 | 18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease | A Prospective Study to Evaluate the Inflammation and Fibrosis of Intestinal Stricture in Patients With Crohn's Disease by 18F-FDG and 68Ga-FAPI PET/CT | Crohn Disease | Diagnostic Test: 18F-FDG and 68Ga-FAPI PET/CT | Peking Union Medical College Hospital | NULL | Not yet recruiting | 18 Years | N/A | All | 30 | Phase 2 | NULL |